ATC code M04

ATC codes
M Musculo-skeletal system
	M01 Anti-inflammatory and antirheumatic products
	M02 Topical products for joint and muscular pain
	M03 Muscle relaxants
	M04 Antigout preparations
	M05 Drugs for treatment of bone diseases
	M09 Other drugs for disorders of the musculo-skeletal system
	A; B; C; D; G; H; QI; J; L; M; N; P; R; S; V;
	A; B; C; D; G; H; QI; J; L; M; N; P; R; S; V;

ATC code M04 Antigout preparations is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.^[1]^[2]^[3] Subgroup M04 is part of the anatomical group M Musculo-skeletal system.^[4]

Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QM04.^[5]

National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.

M04A Antigout preparations[]

M04AA51 Allopurinol, combinations

^ "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.
^ World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
^ "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
^ "ATC/DDD Index 2022: code M04". WHO Collaborating Centre for Drug Statistics Methodology.
^ "ATCvet Index 2022: code QM04". WHO Collaborating Centre for Drug Statistics Methodology.